Rallybio Corp (RLYB) Social Stream
RALLYBIO CORP (RLYB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering RALLYBIO CORP.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
RLYB's average price target has moved up $1.33 over the prior 48 weeks.
Over the past 39 weeks, RLYB's average upside potential has been 162.74%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RLYB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 26 weeks, RLYB's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, RALLYBIO CORP's number of analysts covering the stock is greater than 91.22% of them.
- RALLYBIO CORP's variance in analysts' estimates is lower than -321.54% of all US stocks.
- RLYB has a greater average analyst price target than 419.04% of stocks in the small market cap category.
- In the context of Pharmaceutical Products stocks, RALLYBIO CORP's upside potential (average analyst target price relative to current price) is higher than 204.28% of them.
Is RLYB a Buy, Hold or Sell? See the POWR Ratings now!